Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. 4 Open-market sale President sold 48,213 shares at $33.93 ($1,635,867)
  2. 4 Open-market sale Chief Financial Officer sold 41,150 shares at $33.93 ($1,396,220)
  3. 4 Open-market sale Chief Executive Officer sold 94,035 shares at $33.93 ($3,190,608)
  4. 4 Grant or award Director acquired 784 shares (grant or award)
  5. 4 Grant or award Director acquired 760 shares (grant or award)
  6. 4 Grant or award Director acquired 1,212 shares (grant or award)
  7. 4/A Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
  8. 4/A Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
  9. 4/A Open-market sale President sold 2,109 shares at $31.20 ($65,801)
  10. 4 Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
  11. 4 Open-market sale President sold 2,109 shares at $31.20 ($65,801)
  12. 4 Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
  13. 4 Open-market sale Chief Financial Officer sold 521 shares at $41.51 ($21,627)
  14. 4 Open-market sale President sold 525 shares at $41.51 ($21,793)
  15. 4 Open-market sale Chief Executive Officer sold 994 shares at $41.51 ($41,261)
  16. 4 Grant or award Chief Financial Officer acquired 69,230 shares (grant or award)
  17. 4 Grant or award President acquired 110,770 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 224,620 shares (grant or award)
  19. 4 Grant or award Director acquired 1,182 shares (grant or award)
  20. 4 Grant or award Director acquired 1,147 shares (grant or award)

Page 4 of 6 · 115 filings